PHE Screening's leaflet for people who are trans or non-binary has been very well received by trans communities and healthcare professionals alike.
NHS Bowel Cancer Screening Programme
Professor Anne Mackie reflects on the hard work and achievements of everyone involved in screening during 2017.
Today we’ve published our new easy guide to bowel scope screening to ensure information about bowel screening is equally accessible to people with learning disabilities and anyone who struggles with written English.
This year, on 17 July, I went to Norfolk and Norwich University Hospital (NNUH) for a colonoscopy. For the uninitiated it’s where a highly trained individual sticks a camera up your bottom. Take it from me, it’s really quite painless, …
Nurse endoscopists already undertake as much of 20% of the workload in an endoscopy unit. NHS Improving Quality initiatives have estimated clinical endoscopists could carry out up to 40% of low risk, high volume endoscopic procedures.
NHS England has published the 2017-18 service specifications for all 11 NHS Screening Programmes. The specifications accompany the 2017-18 agreement that outlines how NHS England commissions certain public health services under section 7A of the National Health Service Act 2006.
The programme will introduce a new improved home test kit for screening from April 2018. It is call a faecal immunochemical test (FIT) and it will replace the guaiac faecal occult blood test (gFOBt). It’s important that GPs and others working in primary care understand this change to the screening programme and its implications for their patients, so here is a brief summary.
We aim to make screening accessible and inclusive for all eligible populations. For people who are trans (transgender) or non-binary (any gender that is not exclusively male or female), inequalities may exist because...
Public Health England doesn’t directly train people how to carry out screening in the NHS. We’d love to visit you all but sadly don’t have the resources to do this.
Bowel cancer is the third most common cancer in the UK and the second leading cause of cancer deaths.